These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 218997

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N, Attie KM, Reiter EO, Saenger P, Baptista J.
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [Abstract] [Full Text] [Related]

  • 4. Responsiveness of growth hormone-deficient children to human growth hormone. Effect of replacement therapy for one year.
    Rudman D, Patterson JH, Gibbas DL.
    J Clin Invest; 1973 May; 52(5):1108-12. PubMed ID: 4700485
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Evidence for dopaminergic stimulation of growth velocity in some hypopituitary children.
    Huseman CA, Hassing JM.
    J Clin Endocrinol Metab; 1984 Mar; 58(3):419-25. PubMed ID: 6420440
    [Abstract] [Full Text] [Related]

  • 7. The response to treatment with pituitary growth hormone: the New Zealand experience.
    Livesey JH, Cuneo RC, Donald RA, Harris RG, Ibberston HK, Costello JM, Holdaway IM, Gluckman PD, Fraser TR, Chapman GE.
    N Z Med J; 1989 Aug 09; 102(873):399-402. PubMed ID: 2761875
    [Abstract] [Full Text] [Related]

  • 8. Effects of human growth hormone administration on growth rate and growth-stimulating activity of serum, measured by lymphocyte bioassay in hypopituitary children.
    Bozzola M, Lorini R, Schimpff RM, Severi F, Job JC.
    Horm Metab Res; 1986 Apr 09; 18(4):264-7. PubMed ID: 3710421
    [Abstract] [Full Text] [Related]

  • 9. Relative importance of growth hormone and sex steroids for the growth at puberty of trunk length, limb length, and muscle width in growth hormone-deficient children.
    Tanner JM, Whitehouse RH, Hughes PC, Carter BS.
    J Pediatr; 1976 Dec 09; 89(6):1000-8. PubMed ID: 993900
    [Abstract] [Full Text] [Related]

  • 10. Kinetics of the somatomedin C/insulin-like growth factor I: response to exogenous growth hormone (GH) in GH-deficient children.
    Blethen SL, Daughaday WH, Weldon VV.
    J Clin Endocrinol Metab; 1982 May 09; 54(5):986-90. PubMed ID: 7037825
    [Abstract] [Full Text] [Related]

  • 11. The effect of administering gonadotropin-releasing hormone agonist with recombinant-human growth hormone (GH) on the final height of girls with isolated GH deficiency: results from a controlled study.
    Saggese G, Federico G, Barsanti S, Fiore L.
    J Clin Endocrinol Metab; 2001 May 09; 86(5):1900-4. PubMed ID: 11344181
    [Abstract] [Full Text] [Related]

  • 12. Medical Research Council of Canada therapeutic trial of human growth hormone: first 5 years of therapy.
    Guyda H, Friesen H, Bailey JD, Leboeuf G, Beck JC.
    Can Med Assoc J; 1975 Jun 07; 112(11):1301-9. PubMed ID: 165002
    [Abstract] [Full Text] [Related]

  • 13. Growth hormone (GH) treatment in short normal children: absence of influence of time of injection and resistance to GH autofeedback.
    Chanoine JP, Vanderschueren-Lodeweyckx M, Maes M, Thiry-Counson G, Craen M, Van Vliet G.
    J Clin Endocrinol Metab; 1991 Dec 07; 73(6):1269-75. PubMed ID: 1955508
    [Abstract] [Full Text] [Related]

  • 14. Renal handling of phosphate can predict height velocity during growth hormone therapy for short children.
    Nishiyama S, Ikuta M, Nakamura T, Tomoeda S, Matsuda I.
    J Clin Endocrinol Metab; 1992 Apr 07; 74(4):906-9. PubMed ID: 1548358
    [Abstract] [Full Text] [Related]

  • 15. Growth hormone is effective in treatment of short stature associated with short stature homeobox-containing gene deficiency: Two-year results of a randomized, controlled, multicenter trial.
    Blum WF, Crowe BJ, Quigley CA, Jung H, Cao D, Ross JL, Braun L, Rappold G, SHOX Study Group.
    J Clin Endocrinol Metab; 2007 Jan 07; 92(1):219-28. PubMed ID: 17047016
    [Abstract] [Full Text] [Related]

  • 16. Lack of seasonal influence on growth hormone therapy.
    Kollipara S, Connors MH.
    Growth; 1985 Jan 07; 49(3):341-5. PubMed ID: 4085901
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Endogenous dopaminergic dysfunction: a novel form of human growth hormone deficiency and short stature.
    Huseman CA, Hassing JM, Sibilia MG.
    J Clin Endocrinol Metab; 1986 Mar 07; 62(3):484-90. PubMed ID: 3080463
    [Abstract] [Full Text] [Related]

  • 19. Growth and growth hormone therapy in children with achondroplasia: a two-year experience.
    Stamoyannou L, Karachaliou F, Neou P, Papataxiarchou K, Pistevos G, Bartsocas CS.
    Am J Med Genet; 1997 Oct 03; 72(1):71-6. PubMed ID: 9295079
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.